ALNYLAM PHARMACEUTICALS INC

CUSIP: 02043QAB3 Class: NOTE 1.000% 9/1

Bank of New York Mellon Corp's Holding History (CIK: 0001390777)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025
Shares 850,000 Value ($000) $1,380 Avg Close — Range —
Q2 2025
Shares 1,700,000 Value ($000) $2,192 Avg Close — Range —
Q1 2025
Shares 1,000,000 Value ($000) $1,155 Avg Close — Range —
Q4 2024
Shares 500,000 Value ($000) $534 Avg Close — Range —
Q3 2024
Shares 600,000 Value ($000) $702 Avg Close — Range —
Q2 2024
Shares 600,000 Value ($000) $647 Avg Close — Range —
Q1 2024
Shares 600,000 Value ($000) $566 Avg Close — Range —
Q4 2023
Shares 600,000 Value ($000) $593 Avg Close — Range —
Q3 2023
Shares 600,000 Value ($000) $557 Avg Close — Range —